Discover 626 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nebraska provides a variety of paid research opportunities for both healthy volunteers and individuals with specific medical concerns. Research institutions in Omaha, Lincoln, and Bellevue are recruiting participants, offering access to advanced treatments and dedicated medical care.
Filter
1
Filter results
Results: 626
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Boston MA, Monroe NY, Pottstown PA, Newark DE,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
for
Prostatic Neoplasms, Castration-Resistant
Location: New York NY, Grand Rapids MI, River Ridge LA,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT04868604
Phase1, Phase2, Recruiting
Home With TablO outcoMEs (HOME) Registry
for
End Stage Renal Disease
Location: Pittsfield MA, New Hyde Park NY, New York NY,
Sponsor: Outset Medical
Sex: All
Age: 15+
Code: NCT04526301
Recruiting
Blood Markers of Early Pancreas Cancer
for
Diabetes Mellitus, Type 2, PreDiabetes, Pancreas Cyst,
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 19+
Code: NCT03568630
Recruiting
Assessment of Eloquent Function in Brain Tumor Patients
for
Primary Brain Tumor, Metastatic Brain Tumor
Location: Omaha NE
Sponsor: University of Nebraska
Sex: All
Age: 19+
Code: NCT01535430
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Providence RI, Farmington CT, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase3, Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: New York NY, Myrtle Beach SC, Durham NC, Miami FL,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast